Based on 15 analysts giving stock ratings to Tyra Biosciences Inc in the past month.
In the current month, TYRA has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. TYRA average Analyst price target in the last month is 47.455.
Based on analysts' estimates, TYRA EPS is projected to reach -0.699 in FY2026Q4, following reported EPS of -0.740 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.74, while Tyra Biosciences IncTYRA's earnings per share (EPS) for the previous quarter was USD -0.69. EPS for the next quarter is expected at USD -0.70.